Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCW0U
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,167
Award facts
- Contract value 100% obligated
- $33,167.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $33,167.12 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Dupixent 300 mg/2 ml pen injectors on December 22, 2025, with completion targeted for December 23, 2025. This non-set-aside contract, issued from the company's Conshohocken, Pennsylvania location, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The IDC, valued at $999,999,999.00 and extending through December 2026, serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated substantial capacity to meet federal procurement requirements through its extensive portfolio of competitively awarded contracts with the DLA Medical Supply Chain. The company's federal contracting history reflects delivery of diverse pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, vaccines, and medical devices. The current award for Dupixent, a biologic medication used to treat conditions such as atopic dermatitis and eosinophilic asthma, supports the Defense Health Agency and other government healthcare systems in fulfilling military medical supply needs.
Quick answers
Who was awarded contract SPE2DR26FCW0U?
SPE2DR26FCW0U was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 22, 2025.
How much is contract SPE2DR26FCW0U worth?
The government has obligated $33,167 on SPE2DR26FCW0U.
Is contract SPE2DR26FCW0U an order under another contract?
Yes. SPE2DR26FCW0U is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCW0U competed?
The extent of competition for SPE2DR26FCW0U was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award